Stig Nordling
Overview
Explore the profile of Stig Nordling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
2468
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Holmberg L, Garmo H, Andersson S, Andren O, Johansson E, Taari K, et al.
N Engl J Med
. 2024 Oct;
391(14):1362-1364.
PMID: 39383464
No abstract available.
2.
Hietikko R, Mirtti T, Kilpelainen T, Tolonen T, Raisanen-Sokolowski A, Nordling S, et al.
World J Urol
. 2024 Apr;
42(1):217.
PMID: 38581590
Purpose: Prostate cancer (PCa) histology, particularly the Gleason score, is an independent prognostic predictor in PCa. Little is known about the inter-reader variability in grading of targeted prostate biopsy based...
3.
Lehto T, Pylvalainen J, Sandeman K, Kenttamies A, Nordling S, Mills I, et al.
Int J Cancer
. 2023 Sep;
154(5):926-939.
PMID: 37767987
Magnetic resonance imaging (MRI) is increasingly used to triage patients for prostate biopsy. However, 9% to 24% of clinically significant (cs) prostate cancers (PCas) are not visible in MRI. We...
4.
Pellinen T, Sandeman K, Blom S, Turkki R, Hemmes A, Valimaki K, et al.
Cancer Res Commun
. 2023 Mar;
2(3):172-181.
PMID: 36874403
Significance: These findings may have a significant impact on clinical decision making as more radical treatments may be recommended for men with a combination of MRI-visible primary tumors and FAP...
5.
Bychkov D, Joensuu H, Nordling S, Tiulpin A, Kucukel H, Lundin M, et al.
J Pathol Inform
. 2022 Feb;
13:9.
PMID: 35136676
Background: Prediction of clinical outcomes for individual cancer patients is an important step in the disease diagnosis and subsequently guides the treatment and patient counseling. In this work, we develop...
6.
Bychkov D, Linder N, Tiulpin A, Kucukel H, Lundin M, Nordling S, et al.
Sci Rep
. 2021 Feb;
11(1):4037.
PMID: 33597560
The treatment of patients with ERBB2 (HER2)-positive breast cancer with anti-ERBB2 therapy is based on the detection of ERBB2 gene amplification or protein overexpression. Machine learning (ML) algorithms can predict...
7.
Eineluoto J, Sandeman K, Pohjonen J, Sopyllo K, Nordling S, Sturenberg C, et al.
Eur Urol Focus
. 2020 Jul;
7(6):1316-1323.
PMID: 32620540
Background: Diagnosing clinically significant prostate cancer (PCa) is challenging, but may be facilitated by biomarkers and multiparametric magnetic resonance imaging (MRI). Objective: To determine the association between biomarkers phosphatase and...
8.
Turkki R, Byckhov D, Lundin M, Isola J, Nordling S, Kovanen P, et al.
Breast Cancer Res Treat
. 2019 May;
177(1):41-52.
PMID: 31119567
Purpose: Recent advances in machine learning have enabled better understanding of large and complex visual data. Here, we aim to investigate patient outcome prediction with a machine learning method using...
9.
Holmstrom O, Linder N, Moilanen H, Suutala A, Nordling S, Stahls A, et al.
PLoS One
. 2019 Mar;
14(3):e0208366.
PMID: 30889174
Background: Detection of lymph node metastases is essential in breast cancer diagnostics and staging, affecting treatment and prognosis. Intraoperative microscopy analysis of sentinel lymph node frozen sections is standard for...
10.
Bill-Axelson A, Holmberg L, Garmo H, Taari K, Busch C, Nordling S, et al.
N Engl J Med
. 2018 Dec;
379(24):2319-2329.
PMID: 30575473
Background: Radical prostatectomy reduces mortality among men with clinically detected localized prostate cancer, but evidence from randomized trials with long-term follow-up is sparse. Methods: We randomly assigned 695 men with...